Form 4: Glaukos Corp Director Kliman Gilbert H Reports Stock Transactions
SEC Form 4
Director Kliman Gilbert H reports exercising stock options and selling shares of Glaukos Corp, along with receiving a grant of restricted stock units.
Summary
- On May 30, 2024, Gilbert H Kliman, a director of Glaukos Corporation, engaged in multiple transactions involving the company's stock.
- Kliman exercised stock options to acquire 5,000 shares at a price of $32.
- Simultaneously, Kliman sold 5,000 shares at $112.
- Additionally, Kliman received 1,716 restricted stock units (RSUs) as part of the Director Compensation Policy, which will vest on the one-year anniversary of the grant date.
- Following these transactions, Kliman directly owns 32,336 shares of Glaukos Corp common stock, which includes 4,125 unvested restricted stock units.
- Kliman also holds 15,000 stock options with an exercise price of $32 and 1,246 stock options with an exercise price of $110.7.
Sentiment
Score: 5
Explanation: Neutral sentiment. The document simply reports transactions without indicating positive or negative performance.
Positives
- The receipt of restricted stock units aligns the director's interests with the long-term performance of the company.
Negatives
- The sale of 5,000 shares by a director could be interpreted negatively by some investors, although it is a relatively small portion of their holdings.
Risks
- There are no specific risks explicitly mentioned in this document.
- However, insider selling can sometimes be perceived as a negative signal by the market.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting of restricted stock units in one year suggests a continued relationship between the director and the company.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders. It provides transparency into the transactions of company directors and officers, allowing investors to monitor their trading activity.
Stakeholder Impact
- The transactions may have a minor impact on shareholders' perception of the company, depending on how they interpret the director's actions.
Key Dates
| Date | Description |
|---|---|
| July 23, 2015 | Date of grant for a stock option with a three-year vesting schedule. |
| May 30, 2024 | Date of the reported transactions: exercising stock options, selling shares, and receiving restricted stock units. |
| May 30, 2025 | Expiration date for 1,246 stock options granted pursuant to the Issuer's Director Compensation Policy. |
| July 23, 2025 | Expiration date for stock options granted on July 23, 2015. |
| May 30, 2034 | Expiration date for 1,246 stock options granted pursuant to the Issuer's Director Compensation Policy. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.